Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial

L. Moll, Frans; Baumgärtner, Iris; R. Jaff, Michael; Nwachuku, Chuke; J.D. Tangelder, Marco; M. Ansel, Gary; L. Adams, George; Zeller, Thomas; H. Rundback, John; Grosso, Michael; Lin, Min; F. Mercur, Michele; Minar, Erich; the ePAD Investigators, for

doi:10.1177/1526602818760488

Public

Edoxaban Plus Aspirin vs Dual Antiplatelet Therapy in Endovascular Treatment of Patients With Peripheral Artery Disease: Results of the ePAD Trial

Published in Journal of Endovascular Therapy • Mar 18, 2018

Authors:

Frans L. Moll

Iris Baumgärtner

Michael R. Jaff

Abstract

PURPOSE: To report a randomized study that investigated the safety (risk of major bleeds) and potential efficacy of edoxaban, an oral anticoagulant that targets the major components of arterial thrombi, to prevent loss of patency following endovascular treatment (EVT). METHODS: Between February 2012...

Subject

Medicine

Aspirin

Arterial disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!